The public offering was led by Perceptive Advisors and Nantahala Capital, with participation from other new institutional biotech investors. Company CEO George Magrath and board chairman Cam Gallagher ...
Warrants to be issued as part of the public offering and concurrent private placement could bring in up to $21.4 million of additional capital 30 days following the release of OPGx-BEST1 DUO-1001 ...
Opus Genetics announces $20 million public offering and $1.5 million private placement for gene therapy development and operations. Opus Genetics, Inc., a clinical-stage biotechnology company ...
QXO, Inc. (NYSE: QXO) (the "Company" or "QXO") today announced that it has entered into purchase agreements with certain ...
For companies seeking to raise capital without the complexities and costs of a public offering, Regulation D under the ...
On March 12, 2025, the SEC dropped a massive amount of changes to their Compliance and Disclosure Interpretations (CDI’s) ...
Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broke ...
The offer and sale of the securities in the private placement as described above are being made in a transaction not involving a public offering and the securities have not been registered under ...
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback